Tag Archives: MRSA
Outpatient staphylococcal (MSSA or MRSA) eradication instructions
Eradication treatment aims to remove Staph. aureus (MRSA or MSSA) and reduce your risk from recurrent skin infection. If the first eradication treatment is unsuccessful, repeat treatment may be required. MRSA= methicillin-resistant Staphylococcus aureus (commonly referred to as golden staph); MSSA = methicillin-susceptible Staphylococcus aureus
Patient advice: recurrent staphylococcal infection
Natural history of recurrent staphylococcal infection Types of Staphylococcus aureus (including MRSA) can cause recurrent skin infections (e.g. boils) in children and adults who are otherwise well. The infections may recur over many months. Eventually the episodes become less frequent or disappear as the body (immune system) learns to deal with them. That may take […]
Q2 Understanding antibiotic resistance and Staphylococcus aureus
Q2 in our JMO pre-test asked: “What is the main mechanism by which the bacterium Staphylococcus aureus becomes resistant to penicillin?” We gave alternatives enumerating basic mechanisms that micro-organisms use (often in combination) to become resistant to an antimicrobial agent (graphic below). Production of penicillinase (i.e. inactivation by a type of beta-lactamase) was the correct answer– more […]
Treatment of boils – Oz GPs reluctant to rely on scalpelmycin rather than antibiotics
Are you following best practice in the management of boils or recurrent skin infection? We’ve previously addressed this matter detailing a NEJM study that indicated that a majority of US doctors surveyed use incision and drainage only. This recent Australian study investigated treatment of community staphylococcal skin abscesses by GPs and showed that a majority do not follow […]
GP HealthPathways released for recurrent Staph. infection, MRSA and MDRO
The HealthPathways site (based on a model from Christchurch, NZ) are used by our local General Practitioners and others to guide management of common syndromes and to provide guides to hospital-based services. MRSA and MDRO (multi-drug-resistant organism) pathways provide guidance in keeping with MDRO management recommended across Hunter New England Health District . The Recurrent Staphylococcal Infection pathway includes […]
A cautionary tale: High usage of topical fusidic acid and rapid clonal expansion of fusidic acid-resistant Staphylococcus aureus
Clinical Infectious Diseases 2014 New Zealand report Researchers from the University of Auckland report that New Zealand, has now developed world’s highest rates of MRSA to topical antibacterial agents.
AIMED - Let's talk about antibiotics 